Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, November 16, 2022
[ Wed, Nov 16th 2022
] - WOPRAI
[ Wed, Nov 16th 2022
] - WOPRAI
[ Wed, Nov 16th 2022
] - WOPRAI
[ Wed, Nov 16th 2022
] - WOPRAI
[ Wed, Nov 16th 2022
] - WOPRAI
[ Wed, Nov 16th 2022
] - WOPRAI
[ Wed, Nov 16th 2022
] - WOPRAI
[ Wed, Nov 16th 2022
] - WOPRAI
[ Wed, Nov 16th 2022
] - WOPRAI
[ Wed, Nov 16th 2022
] - WOPRAI
[ Wed, Nov 16th 2022
] - WOPRAI
[ Wed, Nov 16th 2022
] - WOPRAI
[ Wed, Nov 16th 2022
] - WOPRAI
[ Wed, Nov 16th 2022
] - WOPRAI
[ Wed, Nov 16th 2022
] - WOPRAI
[ Wed, Nov 16th 2022
] - WOPRAI
Tue, November 15, 2022
[ Tue, Nov 15th 2022
] - WOPRAI
[ Tue, Nov 15th 2022
] - WOPRAI
[ Tue, Nov 15th 2022
] - WOPRAI
[ Tue, Nov 15th 2022
] - WOPRAI
[ Tue, Nov 15th 2022
] - WOPRAI
[ Tue, Nov 15th 2022
] - WOPRAI
[ Tue, Nov 15th 2022
] - WOPRAI
[ Tue, Nov 15th 2022
] - WOPRAI
[ Tue, Nov 15th 2022
] - WOPRAI
[ Tue, Nov 15th 2022
] - WOPRAI
[ Tue, Nov 15th 2022
] - WOPRAI
[ Tue, Nov 15th 2022
] - WOPRAI
Kyle Mikson Maintained (XGN) at Strong Buy with Decreased Target to $7 on, Nov 15th, 2022
Kyle Mikson of Canaccord Genuity, Maintained "Exagen Inc." (XGN) at Strong Buy with Decreased Target from $8 to $7 on, Nov 15th, 2022.
Kyle, nor any peers, have made any analyst calls on XGN in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30